11,28,000 Equity Shares allotted pursuant to conversion of warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 2.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shelter Pharma Ltd has allotted 11,28,000 equity shares after certain warrant holders opted to convert their warrants into shares. These warrants were originally issued on August 6, 2025, as part of a preferential allotment of 88,08,000 convertible warrants at ₹42.25 per warrant. The warrant holders paid the remaining 75% of the issue price (₹31.6875 per share), bringing in ₹3.57 crore to the company. Both promoter group members and non-promoters participated in this conversion (5 investors in total, of which 2 are from the promoter group). As a result, the company's paid-up share capital has increased from 1,28,73,792 shares to 1,40,01,792 shares, an increase of about 8.76%.
Existing shareholders face a modest dilution of roughly 8.76% in their holding due to the share count increase, while the company receives an additional ₹3.57 crore in funds. The conversion by promoter group members signals their continued commitment to the company.